2021-2025 Global Drugs of Abuse Testing Market for 12 Assays-Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
This new 318-page report from LeadingMarketResearch.com contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
The report is available by section, and can be customized to specific information needs and budget.
The report provides test volume and sales forecasts by country and market segment for the following assays:
This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay.
Contains 318 pages and 68 tables
The report is available by section, and can be customized to specific information needs and budget.
The report provides test volume and sales forecasts by country and market segment for the following assays:
- Amphetamines
- Antidepressants
- Barbiturates
- Benzodiazepines
- Cannabinoids/Marijuana
- Cocaine
- LSD
- Methadone
- Methaqualone
- Opiates
- Phencyclidine (PCP)
- Propoxphene
This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay.
Contains 318 pages and 68 tables
INTRODUCTION
WORLDWIDE @MARKET AND TECHNOLOGY OVERVIEW
A. Major Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Antidepressants
5. Barbiturates
6. Benzodiazepines
7. Cannabinoids/Marijuana
8. Cocaine
9. Lysergic Acid Diethylamide (LSD)
10. Methadone
11. Methaqualone
12. Opiates
13. Phencyclidine
14. Propoxphene
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers.
C. Major In Vitro Diagnostic Technologies and Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
D. Market Size, Growth and Major Supplier Shares
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako
WORLDWIDE @MARKET AND TECHNOLOGY OVERVIEW
A. Major Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Antidepressants
5. Barbiturates
6. Benzodiazepines
7. Cannabinoids/Marijuana
8. Cocaine
9. Lysergic Acid Diethylamide (LSD)
10. Methadone
11. Methaqualone
12. Opiates
13. Phencyclidine
14. Propoxphene
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers.
C. Major In Vitro Diagnostic Technologies and Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
D. Market Size, Growth and Major Supplier Shares
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako